Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multicenter Study on HIV-associated Hodgkin Lymphoma

NCT01468740 is registered in ClinicalTrials.gov with Harlachinger Krebshilfe e.V. as lead sponsor.

NCT NCT01468740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01468740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multicenter Study on HIV-associated Hodgkin Lymphoma
Lead sponsor
Harlachinger Krebshilfe e.V.
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2004
Completion date
July 31, 2012
Enrollment
130 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-associated hodgkin lymphoma